AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox


The whale's strategy has been one of aggressive cost averaging. By continuously adding to the 5x leveraged short position during ZEC's upward swings, the trader has lowered their average entry price from $336 to $305.9127, while the current price of $453 has pushed the liquidation price to $1,312.58-a level that, while distant, remains within the realm of possibility given ZEC's recent parabolic trajectory
. Over the past month, the whale has to stave off margin calls, a desperate but calculated move to extend the position's lifespan.This behavior reflects a broader trend in Q4 2025: traders doubling down on leveraged bets amid market uncertainty. Hyperliquid's ecosystem, which saw $500 million in losses from cascading margin calls in a single 24-hour period, exemplifies the fragility of such strategies. With 78% of perpetual futures volume amplifying volatility through feedback loops, even minor price movements can trigger disproportionate losses
.While the short position's survival hinges on ZEC's price trajectory, the order book tells a different story. Large long positions now dominate the
market, with the largest bullish bet valued at $22.29 million at 5x leverage. This position, with an unrealized profit of $8.28 million and a liquidation price of $358.44, represents a stark contrast to the short's precarious state . Another long position, which grew from $410 to $55,000 ZEC in five days, has generated $5.65 million in unrealized gains, further signaling institutional confidence in ZEC's upward .Technical indicators corroborate this bullish narrative. ZEC's relative strength index (RSI) has soared to 94.24, the highest in its history, and has remained above 70 since late September-a prolonged overbought condition that historically precedes sharp corrections
. Analysts like Arthur Hayes have warned of a potential "violent end" to ZEC's 1,500% surge, but the current order book dynamics suggest a short squeeze may materialize before any such correction occurs.Hyperliquid's funding rates for ZEC have become a critical barometer of market sentiment. As shorts face mounting losses, the platform's perpetual futures contracts have seen a shift in funding rate dynamics, with longs increasingly subsidized by struggling short positions. This imbalance creates a self-reinforcing cycle: rising prices force shorts to add margin, which further drives up funding costs for remaining short sellers
.The most alarming signal, however, comes from a high-risk trader who recently opened a $2.73 million short at 10x leverage, setting a liquidation price of $727.45. This bet, placed amid ZEC's all-time highs, underscores the market's polarized expectations but also highlights the fragility of such positions in a rapidly shifting environment
.The ZEC short squeeze on Hyperliquid is no longer a theoretical risk-it is an unfolding crisis. The whale's $25 million position, bolstered by $36.814 million in added collateral, represents a last-ditch effort to avoid liquidation. Yet, with ZEC's RSI at record highs and long positions dominating the order book, the odds of a sustained price reversal are slim.
For investors, the lesson is clear: leveraged short positions in volatile assets like ZEC are inherently precarious, especially in markets where systemic risks are amplified by high leverage and interconnected derivatives. As the Federal Reserve's monetary tightening and geopolitical tensions continue to ripple through crypto markets, the ZEC short squeeze may serve as a cautionary tale for the broader industry.
AI Writing Agent which covers venture deals, fundraising, and M&A across the blockchain ecosystem. It examines capital flows, token allocations, and strategic partnerships with a focus on how funding shapes innovation cycles. Its coverage bridges founders, investors, and analysts seeking clarity on where crypto capital is moving next.

Dec.04 2025

Dec.04 2025

Dec.04 2025

Dec.04 2025

Dec.04 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet